april
novel
coronavim
associ
case
sever
acut
respiratori
syndrom
sar
first
isol
sequenc
canada
genom
sar
coronavim
sarscov
nucleotid
length
known
open
read
frame
orf
although
genom
organ
vim
similar
coronavims
phylogenet
analys
sequenc
align
show
sarscov
close
relat
previous
character
coronavims
show
homolog
bovin
coronavims
murin
hepat
vim
human
strain
coronavims
suggest
origin
host
homo
sapien
epidem
situat
sar
platform
stage
sinc
broken
sever
provinc
china
new
case
everi
day
total
case
report
reach
may
incub
period
diseas
last
week
earli
rapid
diagnost
approach
import
quarantin
sourc
infect
protect
healthi
popul
current
laboratori
examin
mainli
immunolog
mean
elisa
colloid
gold
indic
paper
molecular
biolog
method
nest
rtpcr
realtim
pcr
research
design
manufactur
oligonucleotid
microarray
consist
thirti
specif
oligonucleotid
accord
sequenc
strain
repres
genom
sar
coronavim
studi
show
sar
oligo
microarray
yield
better
diagnost
result
synthes
bioasia
co
label
univers
primer
synthes
trilink
biotechnolog
inc
reagent
depc
polyllysin
sigma
silanl
slide
dako
dmso
formamid
amresco
succin
anhydrid
aldrich
aldrich
sodium
borat
merkschuchardt
oligo
probe
synthes
institut
use
abi
dna
synthes
ii
extrat
viru
rna
rna
sarscov
extract
phenolfreez
protocol
sampl
treat
water
satur
phenol
c
min
put
ice
bath
immedi
phenol
crystal
appear
rna
phenol
chloroform
extract
ethanolprecipit
resuspend
fll
depc
treat
water
iii
revers
transcript
ds
cdna
iv
digest
cdna
restrict
enzym
cdna
taken
fll
fll
xh
buffer
fll
ad
total
volum
fll
c
h
enzym
inactiv
c
min
digest
fragment
cohes
end
gatc
side
v
add
adaptor
digest
fragment
two
primer
sip
flgfll
sir
flgfll
denatur
c
min
cool
c
gradual
min
anneal
doublestrand
univers
adaptor
form
fll
digest
ds
cdna
fll
adaptor
fll
dna
ligas
fll
x
dna
ligas
buffer
fll
ddh
ad
eppendorf
tube
mixtur
kept
c
h
product
purifi
pharmacia
centrifug
tube
remov
adaptor
short
fragment
elut
solut
collect
templat
fluoresc
label
vi
fluoresc
label
adaptorlig
ds
cdna
label
univers
primer
design
accord
sequenc
adaptor
restrict
site
label
reaction
includ
fll
x
pcr
buffer
mmoll
kcl
mmoll
trishcl
ph
mmoll
mgcb
fll
adaptorlig
ds
cdna
fragment
fll
label
univers
primer
fll
ddh
fll
taq
dna
polymeras
pcr
amplif
perform
abi
pcr
system
initi
denatur
temperatur
c
min
follow
cycl
c
c
min
c
final
extens
min
c
vii
design
oligo
microarray
thirti
oligo
design
accord
follow
principl
till
valu
oligo
within
c
ii
contigu
singl
nucleotid
tract
longer
base
iii
hairpin
structur
length
longer
iv
oligo
less
ident
sequenc
blast
compar
v
oligo
contigu
base
similar
sequenc
blast
comparison
x
microarray
design
oligo
neg
blank
control
composit
characterist
oligo
shown
tabl
scheme
microarray
shown
fig
vii
prepar
oligonucleotid
microarray
dako
silanl
slide
coat
polyllysin
accord
protocol
brown
lab
stanford
univers
store
room
temperatur
readi
use
oligo
synthes
abi
dna
synthes
dissolv
dmso
reach
final
concentr
flgfll
hbv
olgio
use
neg
control
dmso
use
blank
control
microarray
print
cartesian
pixsi
robot
rehybrid
x
ssc
solut
face
place
baker
c
snap
dri
biorad
uv
crosslink
use
immobil
probe
onto
slide
mj
slide
treat
block
solut
ml
g
succin
anhydrid
ml
moll
nabor
ph
store
later
use
viii
hybrid
scan
fll
label
sampl
taken
mix
equal
volum
x
hybrid
buffer
formamid
x
ssc
sd
mixtur
denatur
c
min
spun
cool
min
maximum
speed
fll
sampl
pipet
onto
microarray
silicon
pretreat
cover
slip
place
top
array
fll
ddh
ad
two
hole
corn
cmt
hybrid
chamber
maintain
humid
hybrid
chamber
seal
submerg
c
waterbath
h
slide
wash
sd
x
sscol
sd
x
ssc
turn
rins
ddh
dehydr
anhydr
alcohol
scan
packard
scanarray
lite
scanner
hybrid
result
sar
clinic
sampl
neg
normal
person
control
scan
condit
laser
power
pmt
shown
fig
among
b
c
four
sar
sampl
hospit
beij
e
f
g
sampl
liu
hua
qiao
hospit
guangzhou
sever
probe
site
show
posit
microarray
oligool
oligo
oligo
oligo
oligo
oligo
oligo
oligo
site
common
sampl
signal
shown
neg
blank
control
probe
site
probe
site
signal
appli
sampl
normal
person
microarray
research
focus
earli
rapid
sensit
etiolog
diagnosi
effect
prevent
satisfactori
treatment
sar
coronavim
determin
pathogen
diseas
immunolog
method
often
effect
later
stage
diseas
depend
emerg
antibodi
serum
method
base
pcr
merit
conveni
easi
use
often
design
amplifi
one
fragment
sar
genom
mean
result
would
affect
sampl
well
preserv
treat
dna
microarray
diagnosi
base
high
throughput
detect
multipl
target
locu
help
increas
diagnost
ratio
monitor
activ
viru
gene
progress
diseas
time
design
specif
oligonucleotid
repres
whole
genom
sar
coronaviru
research
print
oligo
microarray
appli
hybrid
sampl
sar
patient
treat
label
rdpcr
judg
result
sampl
hybrid
probe
microarray
signal
neg
blank
probe
site
although
differ
among
sampl
common
featur
shown
hybrid
pictur
exampl
four
sampl
includ
b
e
g
hybrid
specif
probe
site
belong
sar
coronaviru
could
provid
import
clue
final
diagnosi
howev
differ
differ
sampl
might
mainli
result
method
sampl
storag
treatment
rna
viru
nucleic
acid
sar
coronaviru
easi
de
grade
ingredi
sputum
complic
may
includ
mani
enzym
bacteria
store
treat
sampl
improperli
target
sequenc
would
lost
unexpectedli
furthermor
although
rd
techniqu
method
amplifi
whole
genom
theori
still
possibl
fragment
could
ligat
adaptor
especi
degrad
sampl
would
caus
preferenti
amplif
fragment
amplifi
well
fragment
inhibit
effect
signific
observ
fig
c
fig
reason
extract
viru
rna
fresh
sampl
immedi
store
low
temperatur
import
improv
accuraci
diagnosi
hand
observ
signal
site
oligo
hybrid
sampl
normal
person
might
due
defect
stringenc
check
oligo
complement
found
two
oligo
flourscent
label
primer
base
correspondingli
probe
although
condit
satisfi
principl
use
design
oligo
discontinu
homolog
present
oligo
human
bac
clone
led
nonspecif
hybrid
three
probe
elimin
array
use
diagnosi
although
oligo
fragment
short
hard
immobil
onto
glass
substanc
oligonucleotid
microarray
still
charact
high
specif
compar
genom
dna
microarray
superior
improv
accuraci
diagnosi
pathogen
oligonucleotid
design
sequenc
specif
belong
sar
coronaviru
order
detect
viru
parallel
specif
part
oligo
common
sequenc
sever
coronavirus
one
oligo
sequenc
belong
sarscov
absolut
specif
would
help
identif
viru
furthermor
design
oligo
directli
known
sequenc
inform
without
necess
isol
pathogen
acquir
whole
genom
dna
applic
would
quick
limit
time
rd
techniqu
initi
method
gene
separ
differenti
display
ds
cdna
digest
restrict
enzym
ligat
adaptor
end
sampl
could
label
fluoresc
univers
primer
pcr
amplif
sampl
fragment
label
method
fluoresc
molecul
end
determin
linear
relat
intens
fluoresc
quantiti
pcr
product
would
help
reflect
origin
statu
sampl
moreov
hybrid
condit
would
easier
control
signal
nois
ratio
lower
fragment
prepar
method
uniform
length
addit
method
could
decreas
consumpt
fluoresc
dye
compar
incorpor
label
fluorescentdntp
could
reduc
cost
microarray
experi
advantag
clinic
applic
